Hims & Hers Health Stock Surges on Novo Nordisk Partnership for Weight-Loss Drug Sales

Hims & Hers Health Inc. experienced a significant premarket stock price surge of around 38-49% following reports that pharmaceutical giant Novo Nordisk plans to sell its popular weight-loss drugs through Hims & Hers Health's platform. This partnership is seen as a major endorsement of Hims & Hers' business model and is expected to open substantial new revenue streams for the company, driving strong investor enthusiasm and a notable increase in market value.

Latest News

03-09

据报导，诺和诺德（Novo Nordisk）与Hims公司的合作关系可能会结束法律纠纷，Hims公司股价随之大涨

03-09

Hims & Hers Shares Double on Report of Wegovy Tie-Up

03-09

Hims & Hers Health股价盘前暴涨37.9%，消息称诺和诺德将通过其平台销售减肥药

User Discussion

NAI500

03-11

From "Bitter Rivals" to "Strong Allies": Hims & Hers Stock Soars 40% Overnight!

$Novo-Nordisk A/S(NVO)$ $Hims & Hers Health Inc.(HIMS)$ Earlier this year, when Novo Nordisk filed a lawsuit against telehealth platform Hims & Hers (HIMS), the market widely believed the latter’s good days were numbered. However, the plot took a dramatic 180-degree turn shortly after—Novo Nordisk not only dropped the lawsuit but also announced a partnership with Hims & Hers, agreeing to introduce its branded weight-loss drugs to the platform for sale at low prices. Fueled by this news, Hims & Hers’ stock surged 40% on Monday, marking one of its largest single-day gains in history. From Lawsuit to Partnership: A Turbulent Feud The relationship between Hims & Hers and Novo Nordisk has be

From "Bitter Rivals" to "Strong Allies": Hims & Hers Stock Soars 40% Overnight!

{"i18n":{"language":"en_US"},"financialEventData":{"themeId":"791f229af9c6be045880f44f4ca9aff5","name":"Hims & Hers Health Stock Surges on Novo Nordisk Partnership for Weight-Loss Drug Sales","description":"Hims & Hers Health Inc. experienced a significant premarket stock price surge of around 38-49% following reports that pharmaceutical giant Novo Nordisk plans to sell its popular weight-loss drugs through Hims & Hers Health's platform. This partnership is seen as a major endorsement of Hims & Hers' business model and is expected to open substantial new revenue streams for the company, driving strong investor enthusiasm and a notable increase in market value.","image":"https://community-static.tradeup.com/news/1201dcc0482be040348fb8d4f228bb68","type":2,"style":4,"follow":false,"createTime":1773047121325,"userCounts":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/special/finance&rndata={\"themeId\":791f229af9c6be045880f44f4ca9aff5}&rnconfig={\"headerBarHidden\": true}","subscribe":false,"allowSubscriptionFinancial":false,"subscriberCount":0,"allowFollow":false,"hasReward":false,"rewardScore":0,"rewardValidDate":0,"rewardEnd":false,"symbols":["HIMS"],"tweetCounts":1,"categoryId":"2929bb7468f5415f853fd96fb35d7c3b","options":[],"votedOptionId":"","totalUserCount":0,"followStatus":false,"themeName":"Hims & Hers Health Stock Surges on Novo Nordisk Partnership for Weight-Loss Drug Sales","tweetAmount":1,"imageIsDefault":false,"aiDerivativeIssues":[]},"news":[{"id":494652,"article_id":"2618647699","title":"据报导，诺和诺德（Novo Nordisk）与Hims公司的合作关系可能会结束法律纠纷，Hims公司股价随之大涨","subtitle":"","subtitle_show":0,"pub_time":1773052273000,"source_id":"reuters_news_zh","language":"zh","url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL4T3ZX0YM:1","is_publish_highlight":0,"symbols_score_info":{"HIMS":1.96,"HIMY":0.6,"HIMZ":0.6,"HIYY":0.6,"HMYY":0.6},"rights":null},{"id":494622,"article_id":"2618642897","title":"Hims & Hers Shares Double on Report of Wegovy Tie-Up","subtitle":"","subtitle_show":0,"pub_time":1773050280000,"source_id":"dowjones_highlight","language":"en","url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":0,"symbols_score_info":{"HIMS":1.97,"HIMY":0.6,"HIMZ":0.6,"HIYY":0.6,"HMYY":0.6,"NVOH":0.6,"NVOX":0.6},"rights":null},{"id":494480,"article_id":"1113739733","title":"Hims & Hers Health股价盘前暴涨37.9%，消息称诺和诺德将通过其平台销售减肥药","subtitle":"","subtitle_show":0,"pub_time":1773043863901,"source_id":"美股速递","language":"zh","url":"","is_publish_highlight":0,"symbols_score_info":{"HIMS":1,"HIMY":1,"HIMZ":1,"HIYY":1,"HMYY":1},"rights":null},{"id":494478,"article_id":"1138397999","title":"Stock Track | Hims & Hers Health Soars 38.56% in Pre-Market on Novo Nordisk Partnership for Weight-Loss Drugs","subtitle":"","subtitle_show":0,"pub_time":1773043575430,"source_id":"ai_movement_en","language":"en","url":"","is_publish_highlight":0,"symbols_score_info":{"HIMS":1},"rights":null},{"id":494479,"article_id":"1186366545","title":"异动解读 | 诺和诺德计划在其平台销售减肥药，Hims & Hers Health盘前暴涨38.56%","subtitle":"","subtitle_show":0,"pub_time":1773043575425,"source_id":"ai_movement_cn","language":"zh","url":"","is_publish_highlight":0,"symbols_score_info":{"HIMS":1},"rights":null},{"id":494481,"article_id":"2618664566","title":"Hims & Hers Health Shares up 37.9% Premarket After Report Novo to Sell Its Weight-Loss Drugs on Co's Platform","subtitle":"","subtitle_show":0,"pub_time":1773043523000,"source_id":"reuters_en_live","language":"en","url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL4N3ZX0PL:1","is_publish_highlight":0,"symbols_score_info":{"HIMS":1.98,"HIMY":0.6,"HIMZ":0.6,"HIYY":0.6,"HMYY":0.6},"rights":null}],"views":[],"tweetList":[{"id":541434451185960,"gmtCreate":1773209876348,"gmtModify":1773211373831,"author":{"id":"4144906086863692","authorId":"4144906086863692","name":"NAI500","avatar":"https://community-static.tradeup.com/news/01a5cfb1c65c21d31f28a3934107c034","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4144906086863692","authorIdStr":"4144906086863692"},"themes":[],"title":"From \"Bitter Rivals\" to \"Strong Allies\": Hims & Hers Stock Soars 40% Overnight!","htmlText":"<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a> <a href=\"https://ttm.financial/S/HIMS\">$Hims &amp; Hers Health Inc.(HIMS)$</a> Earlier this year, when Novo Nordisk filed a lawsuit against telehealth platform Hims &amp; Hers (HIMS), the market widely believed the latter’s good days were numbered. However, the plot took a dramatic 180-degree turn shortly after—Novo Nordisk not only dropped the lawsuit but also announced a partnership with Hims &amp; Hers, agreeing to introduce its branded weight-loss drugs to the platform for sale at low prices. Fueled by this news, Hims &amp; Hers’ stock surged 40% on Monday, marking one of its largest single-day gains in history. From Lawsuit to Partnership: A Turbulent Feud The relationship between Hims &amp; Hers and Novo Nordisk has be","listText":"<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a> <a href=\"https://ttm.financial/S/HIMS\">$Hims &amp; Hers Health Inc.(HIMS)$</a> Earlier this year, when Novo Nordisk filed a lawsuit against telehealth platform Hims &amp; Hers (HIMS), the market widely believed the latter’s good days were numbered. However, the plot took a dramatic 180-degree turn shortly after—Novo Nordisk not only dropped the lawsuit but also announced a partnership with Hims &amp; Hers, agreeing to introduce its branded weight-loss drugs to the platform for sale at low prices. Fueled by this news, Hims &amp; Hers’ stock surged 40% on Monday, marking one of its largest single-day gains in history. From Lawsuit to Partnership: A Turbulent Feud The relationship between Hims &amp; Hers and Novo Nordisk has be","text":"$Novo-Nordisk A/S(NVO)$ $Hims & Hers Health Inc.(HIMS)$ Earlier this year, when Novo Nordisk filed a lawsuit against telehealth platform Hims & Hers (HIMS), the market widely believed the latter’s good days were numbered. However, the plot took a dramatic 180-degree turn shortly after—Novo Nordisk not only dropped the lawsuit but also announced a partnership with Hims & Hers, agreeing to introduce its branded weight-loss drugs to the platform for sale at low prices. Fueled by this news, Hims & Hers’ stock surged 40% on Monday, marking one of its largest single-day gains in history. From Lawsuit to Partnership: A Turbulent Feud The relationship between Hims & Hers and Novo Nordisk has be","images":[{"img":"https://community-static.tradeup.com/news/62e040c4d73c741662d709873cd4f330","width":"1035","height":"250"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/541434451185960","isVote":1,"tweetType":1,"viewCount":927,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0}]}